Topics in this newsletter include:

  • PRO: Recombinant Activated Factor VII Should Be Used Early After Cardiac Surgery
  • CON: Recombinant Activated Factor VII Should Only Be Used as Salvage Therapy After Cardiac Surgery
  • PRO: Start the Drip
  • CON: Avoid the Loop
  • Concise Review
  • Literature Review I
  • Literature Review II
  • Literature Review III: Exploring Intensive Insulin Therapy In-Depth
  • Fellowship Review I: Yale University, Department of Anesthesiology Critical Care
  • Fellowship Review II: Columbia University
  • Fellowship Review III: Johns Hopkins Critical Care Fellowship